Rationale and design of the ‘aldosterone receptor blockade in diastolic heart failure’ trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in pa-Reference-Cited by-同舟云学术

Rationale and design of the ‘aldosterone receptor blockade in diastolic heart failure’ trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in pa

Published:2010-08 Issue:8 Volume:12 Page:874-882
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Edelmann Frank¹,Schmidt Albrecht G.²,Gelbrich Götz³,Binder Lutz⁴,Herrmann-Lingen Christoph⁵,Halle Martin⁶,Hasenfuss Gerd¹,Wachter Rolf¹,Pieske Burkert²

Affiliation:

1. Department of Cardiology and Pneumology; University of Göttingen; Robert-Koch-Str. 40 D-37075 Göttingen Germany

2. Department of Cardiology; University of Graz; Auenbrugger Platz 15 A-8036 Graz Austria

3. Coordination Center for Clinical Trials Leipzig; University of Leipzig; Härtelstr. 16-18 D-04107 Leipzig Germany

4. Department of Clinical Chemistry; University of Göttingen; Robert-Koch-Str. 40 D-37075 Göttingen Germany

5. Department of Psychosomatic Medicine and Psychotherapy; University of Göttingen; von-Siebold-Str. 5 D-37075 Göttingen Germany

6. Department of Preventive and Rehabilitative Sports Medicine; Technical University Munich; Connollystr. 32 D-80809 Munich Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfq087/fullpdf

Reference51 articles.

1. Congestive heart failure in the community: trends in incidence and survival in a 10-year period;Senni;Arch Intern Med,1999

2. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006

3. Systolic and diastolic heart failure in the community;Bursi;JAMA,2006

4. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

5. Long-term trends in the incidence of and survival with heart failure;Levy;N Engl J Med,2002

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum aldosterone in right ventricular failure versus left ventricular failure before and after mineralocorticoid receptor antagonists: case-control clinical trial;Acta Cardiologica;2023-10-09

2. Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial;BMC Cardiovascular Disorders;2023-04-05

3. NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-10-12

4. Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction;ESC Heart Failure;2021-09-04

5. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2021-05-22